1. Home
  2. DFTX vs PSN Comparison

DFTX vs PSN Comparison

Compare DFTX & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo Parsons Corporation

PSN

Parsons Corporation

SELL

Current Price

$49.58

Market Cap

5.2B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
DFTX
PSN
Founded
N/A
1944
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.2B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
DFTX
PSN
Price
$30.21
$49.58
Analyst Decision
Strong Buy
Buy
Analyst Count
19
14
Target Price
★ $72.83
$61.36
AVG Volume (30 Days)
★ 1.5M
1.0M
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.77
EPS
N/A
★ 0.85
Revenue
N/A
★ $6,364,245,000.00
Revenue This Year
N/A
$0.14
Revenue Next Year
N/A
$4.75
P/E Ratio
★ N/A
$58.79
Revenue Growth
★ N/A
N/A
52 Week Low
$14.62
$36.26
52 Week High
$49.70
$86.70

Technical Indicators

Market Signals
Indicator
DFTX
PSN
Relative Strength Index (RSI) 37.55 53.43
Support Level $20.43 $49.38
Resistance Level $38.59 $53.25
Average True Range (ATR) 2.10 2.24
MACD -0.21 -0.27
Stochastic Oscillator 3.34 37.87

Price Performance

Historical Comparison
DFTX
PSN

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.

Share on Social Networks: